Products Categories
CAS No.: | 56796-39-5 |
---|---|
Name: | Cefmetazole sodium |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C15H16N7NaO5S3 |
Molecular Weight: | 493.524 |
Synonyms: | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R,7S)- (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R-cis)-;CS-1170 sodium salt;Cefmetazole sodium;Cefmetazole-Na;Cefmetazon;Cefmetazone;Metafar;Sodium cefmetazole;Zefazone; |
EINECS: | 260-384-2 |
Density: | 1.75 g/cm3 |
Solubility: | Soluble in water |
Appearance: | White solid |
Hazard Symbols: | Xi |
Risk Codes: | 36/37/38-42/43 |
Safety: | 26-36 |
PSA: | 242.06000 |
LogP: | -1.73422 |
IUPAC Name: Sodium (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Systematic of Cefmetazole sodium (CAS NO.56796-39-5): Cefmetazole sodium [USAN:JAN] ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-cis)- ; CMZ sodium ; CS 1170 sodium ; Cefmetazon ; SKF 83088 sodium ; Sodium (6R,7S)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate ; U 72791A ; UNII-37Y9VR4W7A ; Zefazone ; Zefazone in plastic container ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, sodium salt, (6R-cis)-
CAS NO: 56796-39-5
Classification Code: Antibacterial ; Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula of Cefmetazole sodium (CAS NO.56796-39-5): C15H16N7NaO5S3
Molecular Weight: 493.5162
Molecular Structure:
ProductCategories: Chiral Reagents ; Heterocycles ; Intermediates & Fine Chemicals ; Pharmaceuticals ; Sulfur & Selenium Compounds ; A - KAntibiotics ; Antibacterial ; Antibiotics A to ; Antibiotics A-FAntibiotics ; Chemical Structure Class ; Interferes with Cell Wall SynthesisAntibiotics ; Mechanism of Action ; Penicillins and Cephalosporins (beta-Lactams) ; Spectrum of Activity
H bond acceptors: 12
H bond donors: 2
Freely Rotating Bonds: 9
Polar Surface Area of Cefmetazole sodium (CAS NO.56796-39-5): 230.44 Å2
Cefmetazole sodium (CAS NO.56796-39-5) is used as antibacterial
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | > 1600mg/kg (1600mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 22, Pg. 123, 1980. | |
mouse | LD50 | intraperitoneal | 10233mg/kg (10233mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. |
mouse | LD50 | intravenous | 8690mg/kg (8690mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. |
mouse | LD50 | oral | 3228mg/kg (3228mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacobio-Dynamics. Vol. 8, Pg. 633, 1985. |
mouse | LD50 | subcutaneous | 12190mg/kg (12190mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. |
rat | LD50 | intraperitoneal | > 7500mg/kg (7500mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. |
rat | LD50 | intravenous | > 5gm/kg (5000mg/kg) | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. | |
rat | LD50 | oral | 3204mg/kg (3204mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacobio-Dynamics. Vol. 8, Pg. 633, 1985. |
rat | LD50 | subcutaneous | > 12500mg/kg (12500mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978. |
Hazard Codes: Xn,Xi
Risk Statements: 36/37/38-42/43
R36/37/38: Irritating to eyes, respiratory system and skin.
R42/43: May cause sensitization by inhalation and skin contact.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clothing.
WGK Germany: 2
RTECS: XI0372200